Patents by Inventor Mary Vinson

Mary Vinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutical use of anti-myelin associated glycoprotein (MAG) antibodies
    Patent number: 8017115
    Abstract: A method of promoting oligodendrocyte survival in a human suffering from, or at risk of developing, stroke or other neurological diseases utilizes anti-MAG antibodies or functional fragments of such antibodies.
    Type: Grant
    Filed: February 2, 2004
    Date of Patent: September 13, 2011
    Assignee: Glaxo Group Limited
    Inventors: Elaine Alison Irving, Mary Vinson
  • Antagonists Of Myelin-Associated Glycoprotein And Their Use In The Treatment And/Or Prevention Of Neurological Diseases
    Publication number: 20080014195
    Abstract: A method of treatment or prophylaxis of stroke and other neurological diseases in a human which comprises administering an effective amount of a MAG antagonist or anti-MAG antibody including altered antibodies and functional fragments thereof.
    Type: Application
    Filed: May 9, 2007
    Publication date: January 17, 2008
    Inventors: Elaine Irving, Mary Vinson
  • Therapeutical Use of Anti-Myelin Associated Glycoprotein (Mag) Antibodies
    Publication number: 20070269427
    Abstract: A method of promoting oligodendrocyte survival in a human suffering from, or at risk of developing, stroke or other neurological diseases utilizes anti-MAG antibodies or functional fragments of such antibodies.
    Type: Application
    Filed: February 2, 2004
    Publication date: November 22, 2007
    Inventors: Elaine Irving, Mary Vinson
  • NOVEL TREATMENT
    Publication number: 20070238757
    Abstract: A method for the promotion of growth and/or repair of neurons in diseases or conditions characterised by neuron degeneration, injury or impaired plasticity which method comprises the administration of an effective, non-toxic and pharmaceutically acceptable amount of a PPAR? agonist or a pharmaceutically acceptable derivative thereof.
    Type: Application
    Filed: June 13, 2007
    Publication date: October 11, 2007
    Inventors: Gayle CHAPMAN, Mary Vinson
  • Methods of treatment with lxr modulators
    Publication number: 20050171084
    Abstract: Disclosed are methods of using compounds that modulate LXR.
    Type: Application
    Filed: March 26, 2003
    Publication date: August 4, 2005
    Inventors: William Cairns, Elaine Irving, Andrew Parsons, Peter Soden, Jill Richardson, Stephen Burbidge, Mary Vinson, Mike Watson, Karl Whitney
  • Antagonists of Myelin-associated Glycoprotein and their use in the treatment and/or prevention of Neurological diseases
    Publication number: 20040170627
    Abstract: A method of treatment or prophylaxis of stroke and other neurological diseases in a human which comprises administering an effective amount of a MAG antagonist or anti-MAG antibody including altered antibodies and functional fragments thereof.
    Type: Application
    Filed: December 17, 2003
    Publication date: September 2, 2004
    Inventors: Elaine Alison Irving, Mary Vinson
  • Novel treatment
    Publication number: 20040077525
    Abstract: A method for the promotion of growth and/or repair of neurons in diseases or conditions characterised by neuron degeneration, injury or impaired plasticity which method comprises the administration of an effective, non-toxic and pharmaceutically acceptable amount of a PPAR&ggr; agonist or a pharmaceutically acceptable derivative thereof.
    Type: Application
    Filed: October 28, 2003
    Publication date: April 22, 2004
    Inventors: Gayle Chapman, Mary Vinson